These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29232843)

  • 1. Recent Development of Non-Peptide GnRH Antagonists.
    Tukun FL; Olberg DE; Riss PJ; Haraldsen I; Kaass A; Klaveness J
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29232843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-peptidic GnRH receptor antagonists.
    Armer RE; Smelt KH
    Curr Med Chem; 2004 Nov; 11(22):3017-28. PubMed ID: 15544487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress towards the development of non-peptide orally-active gonadotropin-releasing hormone (GnRH) antagonists: therapeutic implications.
    Millar RP; Zhu YF; Chen C; Struthers RS
    Br Med Bull; 2000; 56(3):761-72. PubMed ID: 11255560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and in vitro evaluation of small-molecule [18F] labeled gonadotropin-releasing hormone (GnRH) receptor antagonists as potential PET imaging agents for GnRH receptor expression.
    Olberg DE; Andressen KW; Levy FO; Klaveness J; Haraldsen I; Sutcliffe JL
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1846-50. PubMed ID: 24613701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-phenyl-4-piperazinylbenzimidazoles: orally active inhibitors of the gonadotropin releasing hormone (GnRH) receptor.
    Pelletier JC; Chengalvala M; Cottom J; Feingold I; Garrick L; Green D; Hauze D; Huselton C; Jetter J; Kao W; Kopf GS; Lundquist JT; Mann C; Mehlmann J; Rogers J; Shanno L; Wrobel J
    Bioorg Med Chem; 2008 Jul; 16(13):6617-40. PubMed ID: 18511284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hexapeptide and cyclic pentapeptide endothelin antagonists directly activate pituitary gonadotropin-releasing hormone receptors.
    Yahalom D; Koch Y; Ben-Aroya N; Fridkin M
    Mol Pharmacol; 2000 Apr; 57(4):718-24. PubMed ID: 10727517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of SKI2670, a novel, orally active, non-peptide GnRH antagonist, on hypothalamic-pituitary-gonadal axis.
    Kim SM; Yoo T; Lee SY; Kim EJ; Lee SM; Lee MH; Han MY; Jung SH; Choi JH; Ryu KH; Kim HT
    Life Sci; 2015 Oct; 139():166-74. PubMed ID: 26321528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mammalian receptor for the evolutionarily conserved type II GnRH.
    Millar R; Lowe S; Conklin D; Pawson A; Maudsley S; Troskie B; Ott T; Millar M; Lincoln G; Sellar R; Faurholm B; Scobie G; Kuestner R; Terasawa E; Katz A
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9636-41. PubMed ID: 11493674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G protein-coupled receptors of the hypothalamic-pituitary-gonadal axis: a case for Gnrh, LH, FSH, and GPR54 receptor ligands.
    Heitman LH; Ijzerman AP
    Med Res Rev; 2008 Nov; 28(6):975-1011. PubMed ID: 18561294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of the hypothalamic-pituitary-gonadal axis by TAK-385 (relugolix), a novel, investigational, orally active, small molecule gonadotropin-releasing hormone (GnRH) antagonist: studies in human GnRH receptor knock-in mice.
    Nakata D; Masaki T; Tanaka A; Yoshimatsu M; Akinaga Y; Asada M; Sasada R; Takeyama M; Miwa K; Watanabe T; Kusaka M
    Eur J Pharmacol; 2014 Jan; 723():167-74. PubMed ID: 24333551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GnRH agonists and antagonists in cancer therapy.
    Chengalvala MV; Pelletier JC; Kopf GS
    Curr Med Chem Anticancer Agents; 2003 Nov; 3(6):399-410. PubMed ID: 14529448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The discovery of novel small molecule non-peptide gonadotropin releasing hormone (GnRH) receptor antagonists.
    Luthin DR; Hong Y; Pathak VP; Paderes G; Nared-Hood KD; Castro MA; Vazir H; Li H; Tompkins E; Christie L; May JM; Anderson MB
    Bioorg Med Chem Lett; 2002 Dec; 12(23):3467-70. PubMed ID: 12419385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical consequences of the administration of a GnRH antagonist during the menstrual cycle].
    Gordon K
    J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S7-10. PubMed ID: 15643677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of a novel nonpeptide antagonist of the human gonadotropin-releasing hormone receptor, NBI-42902.
    Struthers RS; Xie Q; Sullivan SK; Reinhart GJ; Kohout TA; Zhu YF; Chen C; Liu XJ; Ling N; Yang W; Maki RA; Bonneville AK; Chen TK; Bozigian HP
    Endocrinology; 2007 Feb; 148(2):857-67. PubMed ID: 17095587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a novel, orally active, small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist.
    Li H; Anderes KL; Kraynov EA; Luthin DR; Do QQ; Hong Y; Tompkins E; Sun ET; Rajapakse R; Pathak VP; Christie LC; Feng J; Vazir H; Castillo R; Gregory ML; Castro M; Nared-Hood K; Paderes G; Anderson MB
    J Med Chem; 2006 Jun; 49(11):3362-7. PubMed ID: 16722655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological characterization of a novel, orally active small molecule gonadotropin-releasing hormone (GnRH) antagonist using castrated and intact rats.
    Anderes KL; Luthin DR; Castillo R; Kraynov EA; Castro M; Nared-Hood K; Gregory ML; Pathak VP; Christie LC; Paderes G; Vazir H; Ye Q; Anderson MB; May JM
    J Pharmacol Exp Ther; 2003 May; 305(2):688-95. PubMed ID: 12606616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a thieno[2,3-d]pyrimidine-2,4-dione bearing a p-methoxyureidophenyl moiety at the 6-position: a highly potent and orally bioavailable non-peptide antagonist for the human luteinizing hormone-releasing hormone receptor.
    Sasaki S; Cho N; Nara Y; Harada M; Endo S; Suzuki N; Furuya S; Fujino M
    J Med Chem; 2003 Jan; 46(1):113-24. PubMed ID: 12502365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropin-releasing-hormone-receptor antagonists.
    Huirne JA; Lambalk CB
    Lancet; 2001 Nov; 358(9295):1793-803. PubMed ID: 11734258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of linzagolix, a novel, orally active, non-peptide antagonist of gonadotropin-releasing hormone receptors.
    Tezuka M; Tamai Y; Kuramochi Y; Kobayashi K; Fushimi N; Kiguchi S
    Clin Exp Pharmacol Physiol; 2022 Oct; 49(10):1082-1093. PubMed ID: 35690889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chicken gonadotropin-releasing hormone receptor that confers agonist activity to mammalian antagonists. Identification of D-Lys(6) in the ligand and extracellular loop two of the receptor as determinants.
    Sun YM; Flanagan CA; Illing N; Ott TR; Sellar R; Fromme BJ; Hapgood J; Sharp P; Sealfon SC; Millar RP
    J Biol Chem; 2001 Mar; 276(11):7754-61. PubMed ID: 11112780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.